Trademark Overview
On Friday, October 17, 2025, a trademark application was filed for CLEARONC with the United States Patent and Trademark Office. The USPTO has given the CLEARONC trademark a serial number of 99449207. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Thursday, March 5, 2026. This trademark is owned by H. Lee Moffitt Cancer Center and Research Institute. The CLEARONC trademark is filed in the Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Downloadable software in the nature of a mobile application for use in the provision of medical consultations; Downloadable software in the nature of a mobile application for use in the provision of medical consultations and diagnoses in the field of cancer; Downloadable software in the nature of a mobile application for use in the provision of medical consultations and advice for clinical trial placement; Downloadable computer programs using artificial intelligence (AI) for use in the provision of medical consultations; Downloadable computer programs using artificial intelligence (AI) for use in the provision of medical consultations and diagnoses in the field of cancer; Downloadable computer programs using artificial intelligence (AI) for use in the provision of medical consultations and advice for clinical trial placement
Online medical consultations rendered in virtual environments; Consulting services in the field of medical care; Consultancy in the field of the medical diagnosis of cancer; Consultancy in the field of the medical treatment of cancer; Consulting services in the field of healthcare; Health care consulting in the field of cancer diagnosis and treatment; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases
Software as a service (SAAS) services featuring software for use in the provision of medical consultations; Software as a service (SAAS) services featuring software for use in the provision of medical consultations and diagnoses in the field of cancer; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in the provision of medical consultations and diagnoses; Software as a service (SAAS) services featuring software using artificial intelligence (AI) for use in the provision of medical consultations in the field of cancer; Software as a service (SAAS) services featuring software for use in the provision of medical consultations and advice for clinical trial placement; Providing temporary use of non-downloadable cloud-based software for use in the provision of medical consultations; Providing temporary use of non-downloadable cloud-based software for use in the provision of medical consultations and diagnoses in the field of cancer; Providi...
